Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications
Drug Metabolism and Disposition · 2026-07 · 54 (7) · 100341
DOI: 10.1016/j.dmd.2026.100341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-07. Verfasst von Lianjin Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh,…. Hauptthemen laut MEDLINE: Machine Learning, Pharmacokinetics, Drug Discovery, Databases, Factual. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Pharmacokinetic (PK) data analysis in drug discovery is challenged by the inherent variability of experimental and clinical study designs, which hinders data integration and predictive modeling. To address this, we have curated a comprehensive, human-derived, and machine learning (ML)-ready PK dataset from authoritative, multiedition sources. This novel resource represents a systematically curated, human-derived PK dataset that integrates compound structures, clinical study design information, and experimental variability annotations, providing a structured foundation for data-driven analysis and modeling of human pharmacokinetics. We first implemented a rigorous standardization and filtering protocol to prepare the ML-ready dataset, and we demonstrated its utility through chemoinformatic analysis and ML classification model evaluations at across multiple classification systems. Fragment analysis showed a clear association between molecular structure and PK behavior, with hydrophilic fragments correlating with low distribution and high excretion, while lipophilic fragments were linked to enhanced absorption and plasma protein binding. By leveraging consensus predictions from an ensemble of classification models trained on calculated properties and molecular descriptors for each PK parameter, we achieved the most accurate predictions: ternary classifiers excelled in total clearance, whereas binary classifiers performed better for the others. In conclusion, this study provides a solid foundation for PK parameter classification and predictive modeling using a well curated human PK dataset. Integrating comprehensive data curation with ML presents a powerful strategy for accelerating drug design and enhancing rational therapeutic decision making. SIGNIFICANCE STATEMENT: Accurate prediction of absorption, distribution, metabolism, and excretion and pharmacokinetics (PK) properties is crucial for drug discovery and development. Data curation and availability is invaluable to the progress of the development of robust machine learning models to predict drug PK behavior. Standardized labeling and/or classification of human PK parameters would provide better interpretability and predictability. Integrating comprehensive data curation with machine learning presents a powerful strategy for accelerating drug design and enhancing rational therapeutic decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
- Center for Drug Discovery & Department of Pharmaceutical and Biomedical Sciences, Northeastern University, Boston, Massachusetts. Electronic address: LXIE@iscb.org.
- Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: JUW79@pitt.edu.
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- National Science Foundation
- National Institute on Aging
- National Institute of General Medical Sciences
- National Institutes of Health
- University of Pittsburgh
Zitieren
APA
Cai, L., McWilliams, M., Zhai, J., Xie, L., & Wang, J. (2026). Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications. Drug Metabolism and Disposition, 54(7), 100341. https://doi.org/10.1016/j.dmd.2026.100341
Vancouver
Cai L, McWilliams M, Zhai J, Xie L, Wang J. Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications. Drug Metabolism and Disposition. 2026;54(7):100341. doi:10.1016/j.dmd.2026.100341
BibTeX
@article{Cai2026,
author = {Cai, Lianjin and McWilliams, Mai and Zhai, Jingchen and Xie, Lei and Wang, Junmei},
title = {Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {7},
pages = {100341},
doi = {10.1016/j.dmd.2026.100341}
}
EUVIMED